News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Drug Company ProStrakan Group Considers Takeover Approach; Already Rejected Norgine Offer but Considering Others Now
November 16, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BBC News -- Drug firm ProStrakan said it has had a number of approaches to buy it. The Galashiels manufacturer has rejected one offer from the Dutch group Norgine but was "beginning to evaluate" other approaches.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
MORE ON THIS TOPIC
M&A
Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity Acquisition
October 26, 2025
·
2 min read
·
Heather McKenzie
Immunology and inflammation
Biogen Grows Immunology Pipeline With Vanqua’s Anti-Inflammatory Molecule
October 24, 2025
·
2 min read
·
Dan Samorodnitsky
Deals
Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy
October 24, 2025
·
2 min read
·
Heather McKenzie
Earnings
‘We’re Not Done’: Roche Plans To Sustain Dealmaking Pace After 89bio
October 23, 2025
·
2 min read
·
Tristan Manalac